A safety screening platform for individualized cardiotoxicity assessment-Reference-Cited by-同舟云学术

A safety screening platform for individualized cardiotoxicity assessment

Published:2024-03 Issue:3 Volume:27 Page:109139
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Schwach Verena^ORCID,Slaats Rolf H.,Cofiño-Fabres Carla,ten Den Simone A.,Rivera-Arbeláez José M.,Dannenberg Maureen,van Boheemen Chiara,Ribeiro Marcelo C.,van der Zanden Sabina Y.,Nollet Edgar E.,van der Velden Jolanda,Neefjes Jacques,Cao Lu,Passier Robert

Funder

Nederlandse Hartstichting

European Research Area Network on Cardiovascular Diseases

Publisher

Elsevier BV

Reference45 articles.

1. Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity;Schwach;Front. Cardiovasc. Med.,2020

2. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer;Shafei;Biomed. Pharmacother.,2017

3. Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer;Nair;Clin. Med. Insights Oncol.,2011

4. Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study;Dabich;Cancer Treat Rep.,1986

5. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin;Qiao;Proc. Natl. Acad. Sci. USA,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes;Chemical Research in Toxicology;2024-07-24

2. Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models;Science Translational Medicine;2024-06-19